A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients: Revision history

View logs for this page

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

curprev 14:2414:24, 21 October 2013‎ Rim Halaby talk contribs‎ 3,790 bytes +22‎ No edit summary

curprev 13:0913:09, 22 September 2013‎ Rim Halaby talk contribs‎ 3,768 bytes 0‎ →‎Study Description
curprev 13:0013:00, 22 September 2013‎ Rim Halaby talk contribs‎ 3,768 bytes −67‎ →‎Secondary Outcomes
curprev 12:5912:59, 22 September 2013‎ Rim Halaby talk contribs‎ 3,835 bytes −8‎ →‎Secondary Outcomes
curprev 12:5912:59, 22 September 2013‎ Rim Halaby talk contribs‎ 3,843 bytes −124‎ →‎Primary Outcomes

curprev 14:2914:29, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ m 3,967 bytes 0‎ Hilda Mahmoudi moved page CSL-112 Trial - Phase 2a to A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients
curprev 13:2813:28, 20 September 2013‎ Twinkle Singh talk contribs‎ 3,967 bytes +4‎ →‎Primary Outcomes
curprev 13:2813:28, 20 September 2013‎ Twinkle Singh talk contribs‎ 3,963 bytes +1‎ →‎Secondary Outcomes
curprev 13:2513:25, 20 September 2013‎ Twinkle Singh talk contribs‎ 3,962 bytes +791‎ No edit summary

curprev 21:5221:52, 19 September 2013‎ Twinkle Singh talk contribs‎ 3,171 bytes +2,565‎ No edit summary

curprev 11:2511:25, 18 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 606 bytes +8‎ →‎Conclusion
curprev 11:2511:25, 18 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 598 bytes +3‎ →‎Methods
curprev 11:2511:25, 18 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 595 bytes −5‎ →‎Results

curprev 23:1123:11, 17 September 2013‎ Rim Halaby talk contribs‎ 600 bytes +600‎ Created page with "__NOTOC__ {{High density lipoprotein}} {{CMG}} ==Objective== To determine the safety, tolerability and pharmacokinetics of a single ascending dose of intravenous infusion of ..."

Retrieved from "https://www.wikidoc.org/index.php/A_Single_Ascending_Dose_Study_Examining_the_Safety_and_Pharmacokinetic_Profile_of_Reconstituted_High_Density_Lipoprotein_(CSL112)_Administered_to_Patients"

Cookies help us deliver our services. By using our services, you agree to our use of cookies.